AbbVie (ABBV) Announces FDA Approval of VUITY 1.25%, the First and Only Eye Drop to Treat Presbyopia
Go back to AbbVie (ABBV) Announces FDA Approval of VUITY 1.25%, the First and Only Eye Drop to Treat Presbyopia| AbbVie (NYSE: ABBV) | Delayed: 264.94 +0.98 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $263.96 | 52 Week High | $68.12 | |||
| Open | $263.07 | 52 Week Low | $50.71 | |||
| Day High | $266.60 | P/E | 57.47 | |||
| Day Low | $261.23 | EPS | $4.61 | |||
| Volume | 583,830 | |||||
